Manuel Buscarlet

From geroscience to precision geromedicine: Understanding and managing aging

Naturally occurring T cell mutations enhance engineered T cell therapies

Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A

DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions